WallStreetZenWallStreetZen

NASDAQ: AVDL
Avadel Pharmaceuticals PLC Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for AVDL

Based on 6 analysts offering 12 month price targets for Avadel Pharmaceuticals PLC

Min Forecast
$12.00+50.75%
Avg Forecast
$18.17+128.23%
Max Forecast
$30.00+276.88%

Should I buy or sell AVDL stock?

Based on 6 analysts offering ratings for Avadel Pharmaceuticals PLC.

Strong Buy
Strong Buy
3 analysts 50%
Buy
3 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although AVDL's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates AVDL as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their AVDL stock forecasts and price targets.

AVDL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-09
lockedlocked$00.00+00.00%2025-03-04
lockedlocked$00.00+00.00%2025-02-11
lockedlocked$00.00+00.00%2025-01-13
lockedlocked$00.00+00.00%2025-01-10
Oppenheimer
Bottom 3%
3
BuyMaintains$30.00+276.88%2024-10-31

1 of 1

Forecast return on equity

Is AVDL forecast to generate an efficient return?

Company
168.49%
Industry
44.61%
Market
81.87%
AVDL's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is AVDL forecast to generate an efficient return on assets?

Company
75.76%
Industry
15.28%
AVDL is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

AVDL earnings per share forecast

What is AVDL's earnings per share in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$0.07
Avg 2 year Forecast
$0.66
Avg 3 year Forecast
$1.16

AVDL revenue forecast

What is AVDL's revenue in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$249.5M+47.54%
Avg 2 year Forecast
$329.7M+94.95%
Avg 3 year Forecast
$406.9M+140.59%
AVDL's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AVDL revenue growth forecast

How is AVDL forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
34.05%
Industry
4.41%
Market
10.37%
AVDL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AVDL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AVDL vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
AVDL$7.96$18.17+128.23%Strong Buy
HROW$23.24$61.00+162.48%Strong Buy
COLL$26.91$44.00+63.51%Buy
PAHC$16.53$23.50+42.17%Sell
CRON$1.74N/AN/A
View Top Pharmaceutical Stocks

Avadel Pharmaceuticals Stock Forecast FAQ

Is Avadel Pharmaceuticals Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: AVDL) stock is to Strong Buy AVDL stock.

Out of 6 analysts, 3 (50%) are recommending AVDL as a Strong Buy, 3 (50%) are recommending AVDL as a Buy, 0 (0%) are recommending AVDL as a Hold, 0 (0%) are recommending AVDL as a Sell, and 0 (0%) are recommending AVDL as a Strong Sell.

If you're new to stock investing, here's how to buy Avadel Pharmaceuticals stock.

What is AVDL's earnings growth forecast for 2025-2027?

(NASDAQ: AVDL) Avadel Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 23.44%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.17%.

Avadel Pharmaceuticals's earnings in 2025 is -$48,832,000.On average, 7 Wall Street analysts forecast AVDL's earnings for 2025 to be $6,329,228, with the lowest AVDL earnings forecast at -$2,898,883, and the highest AVDL earnings forecast at $16,427,004. On average, 5 Wall Street analysts forecast AVDL's earnings for 2026 to be $63,524,191, with the lowest AVDL earnings forecast at $20,978,250, and the highest AVDL earnings forecast at $86,000,197.

In 2027, AVDL is forecast to generate $112,012,841 in earnings, with the lowest earnings forecast at $45,048,643 and the highest earnings forecast at $139,146,386.

What is AVDL's revenue growth forecast for 2025-2027?

(NASDAQ: AVDL) Avadel Pharmaceuticals's forecast annual revenue growth rate of 34.05% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.41%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.37%.

Avadel Pharmaceuticals's revenue in 2025 is $169,117,000.On average, 6 Wall Street analysts forecast AVDL's revenue for 2025 to be $24,110,879,992, with the lowest AVDL revenue forecast at $23,244,210,589, and the highest AVDL revenue forecast at $24,611,517,095. On average, 5 Wall Street analysts forecast AVDL's revenue for 2026 to be $31,857,565,166, with the lowest AVDL revenue forecast at $26,687,503,876, and the highest AVDL revenue forecast at $35,604,081,620.

In 2027, AVDL is forecast to generate $39,316,294,624 in revenue, with the lowest revenue forecast at $31,372,582,032 and the highest revenue forecast at $47,901,143,518.

What is AVDL's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: AVDL) forecast ROA is 75.76%, which is higher than the forecast US Drug Manufacturers - Specialty & Generic industry average of 15.28%.

What is AVDL's Price Target?

According to 6 Wall Street analysts that have issued a 1 year AVDL price target, the average AVDL price target is $18.17, with the highest AVDL stock price forecast at $30.00 and the lowest AVDL stock price forecast at $12.00.

On average, Wall Street analysts predict that Avadel Pharmaceuticals's share price could reach $18.17 by Apr 9, 2026. The average Avadel Pharmaceuticals stock price prediction forecasts a potential upside of 128.23% from the current AVDL share price of $7.96.

What is AVDL's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: AVDL) Avadel Pharmaceuticals's current Earnings Per Share (EPS) is -$0.51. On average, analysts forecast that AVDL's EPS will be $0.07 for 2025, with the lowest EPS forecast at -$0.03, and the highest EPS forecast at $0.17. On average, analysts forecast that AVDL's EPS will be $0.66 for 2026, with the lowest EPS forecast at $0.22, and the highest EPS forecast at $0.89. In 2027, AVDL's EPS is forecast to hit $1.16 (min: $0.47, max: $1.44).

What is AVDL's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: AVDL) forecast ROE is 168.49%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.